NCT03225183View on ClinicalTrials.gov

RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2

CompletedOBSERVATIONAL
Enrollment

1,700

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

March 15, 2019

Study Completion Date

June 17, 2019

Conditions
Cardiovascular DiseaseHypertension
Trial Locations (1)

01702

Framingham Heart Study, Framingham

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03225183 - RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 | Biotech Hunter | Biotech Hunter